Antimitotic and antiproliferative activities of chalcones: Forward structure-activity relationship

Journal of Medicinal Chemistry

Volumn 51, Issue 7, 2008, Pages 2307-2310

  Boumendjel, Ahcène ^a,e   Boccard, Julien ^b   Carrupt, Pierre Alain ^b   Nicolle, Edwige ^a   Blanc, Madeleine ^a   Geze, Annabelle ^a   Choisnard, Luc ^a   Wouessidjewe, Denis ^a   Matera, Eva Laure ^c,d   Dumontet, Charles ^c,d  

^a Centre National de la Recherche Scientifique   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITÉ DE LYON   (France)

^d INSERM   (France)

^e Université Joseph Fourier   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; CHALCONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENTIATION; EVALUATION; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKEMIA CELL; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

EID: 41849087682     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0708331     Document Type: Article

References (21)

1. Kiselyov, Al.; Balakin, K. V.; Tkachenko, S. E.; Savchuk, N.; Ivachtchenko, A. V. Recent progress in discovery and development of antimitotic agents. Anti-Cancer Agents Med. Chem. 2007, 7, 189-208.
2. Nagle, A.; Hur, W.; Gray, N. S. Antimitotic agents of natural origin. Curr. Drug Targets 2006, 7, 305-326.
3. Harborne, J. B.; Williams, C. A. Advances in flavonoid research since 1992. Phytochemistry 2000, 55, 481-504.
4. Roger, C. R. The nutritional incidence of flavonoids: some physiological and metabolic considerations. Experientia 1988, 44, 725-733.
5. Lopez-Lazaro, M. Flavonoids as anticancer agents: Structure-activity relationship study. Curr. Med. Chem 2002, 2, 691-714.
6. Blagosklonny, M. V. Flavopiridol, an inhibitor of transcription. Implications, problems and solutions. Cell Cycle 2004, 3, 1537-1542.
7. Go, M. L.; Wu, X.; Liu, X. L. Chalcones: An update on cytotoxic and chemopreventive properties. Curr. Med. Chem. 2005, 12, 483-499.
8. Cabrera, M.; Simoens, M.; Falchi, G.; Lavaggi, M.-L.; Piro, O. E.; Castellano, E. E.; Vidal, A.; Azqueta, A.; Monge, A.; Lopez de Cerain, A.; Sagrera, G.; Seoane, G.; Cerecetto, H.; Gonzalez, M. Synthetic chalcones, flavanones, and flavones as antitumoral agents: Biological evaluation and structure-activity relationships. Bioorg. Med. Chem. 2007, 15, 3356-3367.
9. Kerr, D. J.; Hamel, E.; Jung, M. K.; Flynn, B. L. The concise synthesis of chalcone, indanone, and indenone analogues of combretastatin A4. Bioorg. Med. Chem. 2007, 15, 3290-3298.
10. Ducki, S. The development of chalcones as promising anticancer agents. IDrugs 2007, 10, 42-46.
11. Robinson, T.-P.; Hubbard, R. B.; Ehlers, T. J.; Arbiser, J. L.; Goldsmith, D. J.; Bowen, J. P. Synthesis and biological evaluation of aromatic enones related to curcumin. Bioorg. Med. Chem. 2005, 13, 4007-4013.
12. Bowen, P. J.; Robinson, T.-P.; Ehlers, T.; Goldsmith, D.; Arbiser, J. Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states. PCT Int. Appl. 2001046110 A2 20010628, 2001.
13. Rao, Y. K.; Fang, S-H.; Tzeng, Y.-M. Differential effects of synthesized 2′-oxygenated chalcone derivative: modulation of human cell cycle phase distribution. Bioorg. Med. Chem. 2004, 12, 2679-2686.
14. Ducki, S.; Forrest, R.; Hadfiled, J. A.; Kendall, A.; Lawrence, N. J.; McGown, A. T.; Rennison, D. Potent antimitotic and cell growth inhibitory properties of substituted chalcones. Bioorg. Med. Chem. Lett. 1998, 8, 1051-1056.
15. Boumendjel, A.; Di Pietro, A.; Dumontet, C.; Barron, D. Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-gp responsible for cancer cell multidrug resistance. Med. Res. Rev. 2002, 22, 512-529.
16. Hadjeri, M.; Peiller, E.-L.; Beney, C.; Deka, N.; Lawson, M.-A.; Dumontet, C.; Boumendjel, A. Antimitotic activity of 5-hydroxy-7-methoxy-2- phenyl-4-quinolones. J. Med. Chem. 2004, 47, 4964-4970.
17. Buckingham, J. Dictionary of natural products on CD-ROM; Chapman & Hall: London, 2001.
18. Deka, N.; Hadjeri, M.; Lawson, M. A.; Beney, C.; Mariotte, A.-M.; Boumendjel, A. Acetylated dimethoxyaniline as a key intermediate for the synthesis of aminoflavones and quinolones. Heterocycles 2002, 57, 123-128.
19. Srinivas, K. V.; Koteswara Rao, Y.; Mahender, I.; Das, B.; Rama Krishna, K. V.; Hara Kishore, K.; Murty, U. S. Flavonoids from Caesalpinia pulcherrima. Phytochemistry 2003, 63, 789-79.
20. Lawrence, N. J.; Patterson, R. P.; Ooi, L.-L.; Cook, D.; Ducki, S. Effects of α-substitutions on structure and biological activity of anticancer chalcones. Bioorg. Med. Chem. Lett. 2006, 16, 5844-5848.
21. 53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity. Br. J. Cancer 2001, 85, 902-908.